2025-03-26 12:26:34
Latest Post
Gujarat Ambuja Exports Ltd commences commercial production of Greenfield 1200 TPD Maize Processing unit
Wardwizard Promoters take decisive action with Significant Fund Infusion
EaseMyTrip signs MoU with Tourism New Zealand to strengthen travel ties and enhance Indian tourist arrivals
Welspun Corp Limited increases stake in Welspun Specialty Solutions Ltd
Rulka Electricals Secures 21 New Work Orders totaling Rs 12.36 Crore in March 2025
Stock Report
Nath Bio-Genes India Ltd Q2FY22 profit slides to Rs. 1.23 crore
Posted On : 2021-11-05 16:18:53( TIMEZONE : IST )
Nath Bio-Genes (India) Limited has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 15.2369 crores during the period ended September 30, 2021 as compared to Rs. 215.1029 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 1.2306 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 44.9116 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 0.65 for the period ended September 30, 2021 as compared to Rs. 23.63 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹15.2369 crs | ₹215.1029 crs |  -92.92% |
| Net Profit | ₹1.2306 crs | ₹44.9116 crs | -97.26% |
| EPS | ₹0.65 | ₹23.63 | -97.25% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs.15.2369 crores during the period ended September 30, 2021 as compared to Rs.23.7152 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.1.2306 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.3.0138 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.0.65 for the period ended September 30, 2021 as compared to Rs.1.59 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹15.2369 crs | ₹23.7152 crs | -35.75% |
| Net Profit | ₹1.2306 crs | ₹3.0138 crs | -59.17% |
| EPS | ₹0.65 | ₹1.59 | -59.12% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.230.3398 crores during the 6 Months period ended September 30, 2021 as compared to Rs.217.3617 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.46.1422 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.44.2713 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.24.28 for the 6 Months period ended September 30, 2021 as compared to Rs.23.30 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹230.3398 crs | ₹217.3617 crs |  5.97% |
| Net Profit | ₹46.1422 crs | ₹44.2713 crs | 4.23% |
| EPS | ₹24.28 | ₹23.30 | 4.21% |
Shares of Nath Bio-Genes (India) Limited was last trading in BSE at Rs. 301.25 as compared to the previous close of Rs. 301.50. The total number of shares traded during the day was 1277 in over 150 trades.
The stock hit an intraday high of Rs. 309.00 and intraday low of 297.25. The net turnover during the day was Rs. 385542.00.
